Flow in a fibril-forming disease
In this issue of Blood, Muchtar and colleagues report on the prognostic value of multiparametric flow cytometry (MFC) to measure clonal plasma cell burden at diagnosis and at end of treatment in patients with amyloid light-chain (AL) amyloidosis.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Blood
Year: 2017, Volume: 129, Issue: 1, Pages: 7-8 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2016-11-746693 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2016-11-746693 Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/129/1/7 |
| Author Notes: | Stefan Schönland and Ute Hegenbart |
| Summary: | In this issue of Blood, Muchtar and colleagues report on the prognostic value of multiparametric flow cytometry (MFC) to measure clonal plasma cell burden at diagnosis and at end of treatment in patients with amyloid light-chain (AL) amyloidosis. |
|---|---|
| Item Description: | Gesehen am 11.07.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2016-11-746693 |